← Back to screener

Electromed, Inc. ELMD

Rank #746 · NYSE · $0.2B market cap
Audited by RSM US LLP, no going-concern flag in the latest filing.
Score
59.4
P/E
29.7
P/B
5.03
ROE
16.9%
Op. Margin
15.1%
Debt Ratio
24%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 29.7x, P/B 5.03x. Ranks in the top 52% of the universe.

Profitability ★★★★☆
Good

ROE 16.9%. Ranks in the top 28% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 24%. Ranks in the top 14% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Good

Revenue growth of 17.0% year over year. Ranks in the top 22% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2012$0.0B$0.0B$0.0B$0.0B9.842
2013$0.0B$0.0B$0.0B$0.0B3.139
2014$0.0B$-0.0B$-0.0B$0.0B-12.126
2015$0.0B$-0.0B$-0.0B$0.0B-4.824
2016$0.0B$0.0B$0.0B$0.0B6.825
2017$0.0B$0.0B$0.0B$0.0B13.530
2018$0.0B$0.0B$0.0B$0.0B13.824
2019$0.0B$0.0B$0.0B$0.0B9.638
2020$0.0B$0.0B$0.0B$0.0B9.016
2021$0.0B$0.0B$0.0B$0.0B15.812
2022$0.0B$0.0B$0.0B$0.0B8.816
2023$0.0B$0.0B$0.0B$0.0B7.122
2024$0.0B$0.0B$0.0B$0.0B8.324
2025$0.1B$0.0B$0.0B$0.0B12.020
2026$0.1B$0.0B$0.0B$0.0B15.124

← See the full screener